Gintuit- the first cell-based FDA approval for mucogingival problems

woman smiling The FDA has approved Gintuit, the first cell-based treatment for mucogingival (mouth and gum) use such as for after gum surgery product. The name is Gintuit and it is a combination of allogenic (not related to the recipient) cells and bovine albumin. While the exact way that it works is not clearly defined, it appears that factors are released which help the situation. More will be written as the data unfolds.

Approval Date: 
Fri, 03/09/2012

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.